BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18427520)

  • 1. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
    Murashko NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):51-5. PubMed ID: 18427520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
    Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vinpotropile in the treatment of cerebral vascular diseases].
    Filimonov VA; Kliueva VN; Kondrasheva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polymorphic effects of cavinton: experimental and clinical evidence].
    Kasatkin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):8-12. PubMed ID: 21465683
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disturbances of brain metabolism in blood circulation disorders and their correction with cavinton].
    Zhloba AA; Nikitina VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(4):67-9. PubMed ID: 16737165
    [No Abstract]   [Full Text] [Related]  

  • 7. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton].
    Kamchatnov PR; Zaĭtsev KA; Chugunov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):52-6. PubMed ID: 20740716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 10. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
    Hadjiev D; Yancheva S
    Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.
    Solti F; Iskum M; Czakó E
    Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subcortical cerebrovascular accidents: correlation between clinical aspects, topography and flow measurements using single photon emission tomography].
    Rapin PA; Bogousslavsky J; Regli F; Assal G; Delaloye B
    Schweiz Med Wochenschr; 1993 Oct; 123(39):1829-36. PubMed ID: 8211035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
    Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of kavinton on bronchial tonus in bronchial asthma patients].
    Karashurov SE
    Eksp Klin Farmakol; 1994; 57(6):35-6. PubMed ID: 7756957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 20. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.